• 

  Zydus Wellness stock split: Why shares fall up to 80% today on some platforms?

  September 18, 2025 13:28 IST

  In five, three and two years, the scrip has yielded a positive return of 36.76, 58.64 and 61.65 per cent, respectively. In one year, the scrip has gained 21.37 per cent, as against a 0.16 per cent correction in the benchmark index.

• 

  Zydus Life Chairman Pankaj R Patel named on RBI Central Board

  Business | June 14, 2022 14:24 IST

  Pankaj Patel was also the President of the Federation of Indian Chamber of Commerce & Industry (FICCI) (2016-17). He is also the Executive Chairman, Vice President and Trustee of the Gujarat Cancer Society and Chairman of the Gujarat Cancer and Research Institute.

• 

  Zydus Lifesciences Q4 profit declines 41% to Rs 397 cr

  May 20, 2022 20:57 IST

  The company had posted a consolidated net profit of Rs 679 crore in the same quarter of previous fiscal year, Zydus Lifesciences said in a regulatory filing.  

• 

  Zydus Cadila gets FDA's approval to market generic cancer drug in US

  World | November 20, 2021 15:54 IST

  The company has received final approval from the US Food and Drug Administration (USFDA) to Decitabine for Injection in the strength of 50 mg/vial single-dose vial, Zydus Cadila said in a statement.  

• 

  Zydus Cadila gets USFDA nod for diabetes medication

  Business | September 06, 2021 13:24 IST

  The NDA received tentative approval upon completion of the first review cycle on September 2, 2021, Zydus Cadila stated.  

• 

  Hope to start supply of ZyCoV-D vaccine by mid to end Sept: Zydus Group MD

  India | August 21, 2021 19:13 IST

  The company's indigenously developed needle-free three-dose COVID-19 vaccine ZyCoV-D was granted emergency use authorisation (EUA) by the drug regulator on Friday, making it the first vaccine to be administered to beneficiaries in the age group of 12-18 years in the country.

• 

  'ZyCoV-D' vaccine 66% efficient against Covid Delta variant: Zydus Group MD

  India | August 23, 2021 15:10 IST

  Zydus Group MD Dr. Sharvil Patel has claimed that 'ZyCoV-D' vaccine holds about 66% efficacy against the Delta variant of COVID-19.

• 

  Zydus Cadila's ZyCoV-D Covid vaccine gets approval for emergency use in India

  News | August 21, 2021 8:20 IST

  The Drugs Controller General of India (DCGI) on Friday gave approval for emergency-use authorization of Zydus Cadila's ZyCoV-D vaccine, the Union Ministry of Science and Technology said. The world’s first and India’s indigenously developed DNA-based vaccine for COVID-19 will be administered in humans including children and adults 12 years and above, the ministry said.

• 

  Zydus Cadila's Covid vaccine ZyCoV-D gets approval for Emergency Use Authorisation

  News | August 20, 2021 21:05 IST

  The Drugs Controller General of India (DCGI) on Friday gave approval for emergency-use authorization of Zydus Cadila's ZyCoV-D vaccine, the Union Ministry of Science and Technology said. The world’s first and India’s indigenously developed DNA-based vaccine for COVID-19 will be administered in humans including children and adults 12 years and above, the ministry said.